QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.30    
    






 

 
 

SECURITIES PURCHASE AGREEMENT
  
    BY AND BETWEEN
  
    VITAL LIVING, INC.
  
    AND
  
    THE INVESTORS    
    







 

Dated
June 7, 2004 







 
 
 

SECURITIES PURCHASE AGREEMENT    
    


        THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is made as of the 7th day of June, 2004, by and between Vital Living, Inc., a Nevada
corporation (the "Company"), and the investors listed on the Schedule of Investors attached hereto as such Schedule may be amended from time to time to include Additional Investors (as defined in
Section 7.12) (each an "Investor" and collectively, the "Investors"). 


W
I T N E S S E T H: 


        WHEREAS,
the Company desires to sell to the Investors, and the Investors desire to purchase from the Company, Units, each Unit consisting of (a) one share of the Company's common
stock, $.0001 par value per share (the "Common Stock"), (b) three Series G warrants ("Series G Warrants"), in the form attached as  Exhibit A hereto, each to purchase one share of
Common Stock and (c) one Series H Warrant ("Series H Warrants" and together
with the Series G Warrants, the "Warrants"), in the form attached as Exhibit B, each to purchase one share of Common Stock, pursuant to
the provisions of this Agreement; and 


        NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties do hereby agree as follows: 


        1.    Purchase and Sale of Units.    



        1.1   Issuance and Sale of Units. Subject to the terms and conditions of this Agreement, the Investors agree to purchase at the
Initial Closing (as hereafter defined), and the Company agrees to issue and sell to the Investors at the Initial Closing, the amount of Units set forth opposite each Investor's name on the Signature
Page hereto, at a per-Unit purchase price of $0.25 ("Purchase Price"). 


        1.2   Closing. 



        (a)   The
Company may close on any amount of Units, up to 4,000,000 Units, without a minimum. The Initial Closing shall take place at the offices of HCFP/Brenner Securities
LLC ("Brenner"), 888 Seventh Avenue, 17th Floor, New York, New York 10106 at 10:00 a.m. at such time and place as the Company and Brenner mutually agree upon orally or in writing. 


        (b)   At
the Initial Closing, the Company shall deliver to the Investors, the Common Stock and the Warrants comprising the Units purchased, against payment of the Purchase
Price per Unit purchased by wire transfer to an account designated by the Company. 


        (c)   The
Company may thereafter effect interim closings (each an "Interim Closing" and each of the Initial Closing and any Interim Closings hereafter referred to as a
"Closing") upon the purchase and sale of additional Units. The Interim Closings may take place at any time thereafter at Brenner's offices at such time and place as the Company and Brenner mutually
agree upon orally or in writing, with the delivery of, and payment for, such additional Units as described in Section 1.2(b) above. 




        2.    Representations and Warranties of the Company.    The Company hereby represents and warrants to the Investors,
except as set forth in the Disclosure Materials (defined below), the following: 



        2.1    Subsidiaries.    The Company does not presently own or control, directly or indirectly, any interest in any
other corporation, association, or other business entity except as disclosed in the SEC Reports (as hereinafter defined) (each, a "Subsidiary" and collectively, the "Subsidiaries"). Unless the context
requires otherwise, all references herein to the "Company" shall refer to the Company and its Subsidiaries. The Company is not a party to any joint venture, partnership, or similar arrangement. 



2







 

        2.2    Organization, Good Standing, and Qualification.    The Company is a corporation duly organized, validly
existing, and in good standing under the laws of the State of Nevada, and has all requisite corporate power and authority to own its properties and assets and to carry on its business as presently
conducted. The Subsidiaries are duly organized in their respective jurisdictions of organization, validly existing and in good standing in such respective jurisdictions and each has the power and
authority to own its properties and assets and to carry on its respective business as now conducted. The Company and the Subsidiaries are duly qualified to transact business and are in good standing
in each jurisdiction where such qualification is required, except where the failure so to qualify could not reasonably be expected to have a Material Adverse Effect (as hereafter defined) on the
Company's business or properties. 


        2.3    Capitalization and Voting Rights.    The number of authorized, issued and outstanding capital stock of the
Company is set forth in the schedule attached hereto as Exhibit C ("Disclosure Schedule"). All outstanding shares have been duly authorized and
are validly issued, fully paid and nonassesasble. Except as disclosed in Exhibit C, no securities of the Company or any Subsidiary are entitled
to preemptive or similar rights, nor is any holder of securities of the Company or any Subsidiary entitled to preemptive or similar rights arising out of any agreement or understanding with the
Company or any Subsidiary by virtue of any of the Transaction Documents (defined hereinafter). Except as disclosed in Exhibit C, there are no
outstanding options, warrants, script rights to subscribe for or acquire calls or commitments of any character whatsoever relating to, or securities, except as a result of the purchase and sale of the
Securities, or rights or obligations convertible into or exchangeable for, or giving any Person (as defined below) any right to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings, or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock, or securities or rights convertible or
exchangeable into shares of Common Stock. To the knowledge of the Company, except as specifically disclosed in the Disclosure Materials, no Person or group of related Persons beneficially owns (as
determined pursuant to Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), or has the right to acquire by agreement with or by
obligation binding upon the Company, beneficial ownership of in excess of 5% of the Common Stock. A "Person" means an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 


        2.4    Authorization.    All corporate action on the part of the Company, its officers, directors, and shareholders
necessary for the due authorization, execution, and delivery of this Agreement, the Ancillary Agreements (as hereafter defined), and the Warrants (collectively, the "Transaction Documents"), the
performance of all obligations of the Company hereunder and thereunder and the due authorization, valid issuance (or reservation for issuance) and delivery of the Common Stock and the Warrants
hereunder and the Common Stock issuable upon exercise of the Warrants (collectively, the "Securities"), has been taken or will be taken prior to the Initial Closing, and the Transaction Documents
constitute or, in the case of the Common Stock and the Warrants, will constitute, valid and legally binding obligations of the Company, enforceable in accordance with their respective terms, except
(i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and similar laws of general application affecting enforcement of creditors' rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, and (iii) to the extent the indemnification provisions contained in the
Transaction Documents may be limited by applicable federal or state laws. 


        2.5    Valid Issuance of Units, Common Stock and Warrants.    The Units, Common Stock and the Warrants being purchased
by the Investors hereunder have been duly and validly authorized and, when issued and delivered in accordance with the terms hereof for the consideration provided 



3







 




for
herein, will be validly issued and will constitute legally binding obligations of the Company in accordance with their terms and will have been issued in compliance with all applicable federal and
state securities laws. The Common Stock issuable upon exercise of the Warrants has been duly and validly reserved for issuance and, upon issuance in accordance with the terms of the Warrants (and upon
payment of the exercise price as required by the Warrants), will be validly issued, fully paid and nonassessable, and will have been issued in compliance with all applicable federal and state
securities laws. 


        2.6    Filings, Consents and Approvals.    Neither the Company nor any Subsidiary is required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents or the consummation of the transactions contemplated thereby, other than (i) the filing of a proper
Form D in accordance with Regulation D promulgated under the Securities Act of 1933, as amended (the "Securities Act" or "Act"), and applicable Blue Sky filings and (ii) in all
other cases where the failure to obtain such consent, waiver, authorization or order, or to give such notice or make such filing or registration could not reasonably be expected to have or result in,
individually or in the aggregate, a material adverse effect on the assets, business, operations, financial condition, liquidity or prospects of the Company and its Subsidiaries taken as a whole
("Material Adverse Effect"). 


        2.7    Litigation.    Except as disclosed in the Disclosure Materials, there is no action, suit, proceeding, claim or
investigation pending or, to the knowledge of the Company, currently threatened against the Company or its affiliates which questions the validity of the Transaction Documents, or the right of the
Company to enter into any of them, or to consummate the transactions contemplated hereby or thereby, or which might result or that could reasonably be expected to have a Material Adverse Effect,
either individually or in the aggregate, or result in any change in the current equity ownership of the Company, nor is the Company aware that there is any basis for the foregoing. The foregoing
includes, without limitation, actions, pending or threatened (or any basis therefor known to the Company), involving the prior employment of any of the Company's employees, their use in connection
with the Company's business of any information or techniques allegedly proprietary to any of their former employers, or their obligations under any agreements with prior employers. The Company is not
a party or subject to any order, writ, injunction, judgment, or decree of any court or government agency or instrumentality. 


        2.8    Patents and Trademarks.    The Company and each of its Subsidiaries owns, or is licensed or otherwise possesses
legally enforceable rights to use all patents, trademarks, trade names, service marks, copyrights, and any applications therefore, technology, know-how, computer software programs or
applications, and tangible or intangible proprietary information or materials that are used in the business of the Company and its Subsidiaries as currently conducted, except for any such failures to
own, be licensed or possess that, individually or in the aggregate, could not reasonably be expected
to have a Material Adverse Effect, and to the knowledge of the officers of the Company all patents, trademarks, trade names, service marks and copyrights held by the Company and/or its Subsidiaries
are valid and subsisting. 




        Except
as disclosed in the Disclosure Materials or as could not reasonably be expected to have a Material Adverse Effect: 



        (a)   the
Company is not, nor will it be as a result of the execution and delivery of the Transaction Documents or the consummation of the transactions contemplated thereby,
in violation of any licenses, sublicenses and other agreements as to which the Company is a party and pursuant to which the Company is authorized to use any third-party patents, trademarks, service
marks, 



4







 

copyrights,
trade secrets or computer software (collectively, "Third-Party Intellectual Property Rights"). 


        (b)   no
claims with respect to (i) the patents, registered and material unregistered trademarks and service marks, registered copyrights, trade names, and any
applications therefore, trade secrets or computer software owned by the Company or any of its Subsidiaries (collectively, the "Company Intellectual Property Rights"); or (ii) Third-Party
Intellectual Property Rights are currently pending or, to the knowledge of the officers of the Company, are threatened by any Person; 



        (c)   the
officers of the Company do not know of any valid grounds for any bona fide claims (i) to the effect that the manufacture, sale, licensing or use of any
product as now used, sold or licensed or proposed for use, sale or license by the Company or any of its Subsidiaries, infringes on any copyright, patent, trademark, service mark or trade secret of any
Person; (ii) against the use by the Company or any of its Subsidiaries, of any Company Intellectual Property Right or Third-Party Intellectual Property Right used in the business of the Company
or any of its Subsidiaries as currently conducted or as proposed to be conducted; (iii) challenging the ownership, validity or enforceability of any of the Company Intellectual Property Rights;
or (iv) challenging the license or legally enforceable right to use of the Third-Party Intellectual Rights by the Company or any of its Subsidiaries; and 


        (d)   to
the knowledge of the officers of the Company, there is no unauthorized use, infringement or misappropriation of any of the Company Intellectual Property Rights by any
third party, including any employee or former employee of the Company or any of its Subsidiaries. 


        2.9    Compliance with Other Instruments.    Except as disclosed in the Disclosure Materials, the Company is not in
violation or default of any provisions of its Amended and Restated Articles of Incorporation or Bylaws or any instrument, judgment, order, writ, decree, mortgage, indenture, lease, license or contract
to which it is a party or by which it is bound or any provision of federal, state, or local statute, rule, or
regulation applicable to the Company, except as could not reasonably be expected, singly or in the aggregate, to have a Material Adverse Effect or to burden or impair the ability of the Company to
consummate the transactions contemplated hereby. The execution, delivery, and performance of the Transaction Documents and the consummation of the transactions contemplated thereby will not result in
any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either a default under any such provision, instrument, judgment, order, writ, decree
or contract, or an event which results in the creation of any lien, charge, or encumbrance upon any assets of the Company or the suspension, revocation, impairment, forfeiture, or nonrenewal of any
material permit, license, authorization, or approval applicable to the Company, its business or operations, or any of its assets or properties, except as could not reasonably be expected, singly or in
the aggregate, to have a Material Adverse Effect. 


        2.10    Permits.    The Company has all franchises, permits, licenses, and any similar authority necessary for the
conduct of its business as now being conducted by it, the lack of which could, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect and believes it can obtain,
without undue burden or expense, any similar authority for the conduct of its business as planned to be conducted. The Company is not in default in any material respect under any of such franchises,
permits, licenses, or other similar authority. 


        2.11    Compliance with Laws.    The conduct of business by the Company and each Subsidiary as presently, conducted or
proposed to be conducted is not subject to continuing oversight, supervision, regulation or examination by any governmental official or body of the United States or any other jurisdiction wherein the
Company or any Subsidiary conducts or proposes to conduct such business, except such regulation as is applicable to commercial enterprises generally. Neither the Company nor any of the Subsidiaries
has received any notice of any violation of or 



5







 




noncompliance
with, any federal, state, local or foreign laws, ordinances, regulations and orders (including, without limitation, those relating to environmental protection, occupational safety and
health, federal securities laws, equal employment opportunity, consumer protection, credit reporting, "truth-in-lending", and warranties and trade practices) applicable to its
business or to the business of any Subsidiary, the violation of, or noncompliance with, which could reasonably be expected to have a Material Adverse Effect, individually or in the aggregate, or
burden or impair the ability of the Company to consummate the transactions contemplated hereby and the Company knows of no facts or set of circumstances which could give rise to such a notice. 


        2.12    Disclosure.    This Agreement, the Common Stock, the Warrants and any other statements or certificates made or
delivered in connection herewith or therewith, when taken together with the Disclosure Materials, do not contain any untrue statement of a material fact or omits to state a material fact necessary to
make the statements herein or therein not misleading. 


        2.13    Title to Property and Assets.    The Company owns its property and assets free and clear of all mortgages,
liens, loans, pledges, security interests, claims, equitable interests, charges, and
encumbrances, except such encumbrances and liens which are disclosed in the Disclosure Materials or which arise in the ordinary course of business and do not materially impair the Company's ownership
or use of such property or assets. With respect to the property and assets it leases, the Company is in compliance with such leases and, to the best of its knowledge, holds a valid leasehold interest
free of any liens, claims, or encumbrances. 


        2.14    Tax Returns, Payments, and Elections.    The Company has timely filed all tax returns and reports as required
by law, and all such returns and reports are true and correct in all material respects. The Company has paid all taxes and other assessments due, if any, except those contested by it in good faith
which are listed in the Schedule of Exceptions. The provisions for taxes of the Company as shown in the Financial Statements is adequate for taxes due or accrued as of the date thereof. The Company
has not elected pursuant to the Internal Revenue Code of 1986, as amended ("Code"), to be treated as a Subchapter S corporation or a collapsible corporation pursuant to Section 341(f) or
Section 1362(a) of the Code. 


        2.15    Insurance.    The Company has in full force and effect fire and casualty insurance policies, with extended
coverage, sufficient in amount (subject to reasonable deductibles) to allow it to replace any of its properties that might be damaged or destroyed, and the Company has insurance against other hazards,
risks, and liabilities to persons and property to the extent and in the manner customary for companies in similar businesses similarly situated. 


        2.16    SEC Reports; Financial Statements.    The Company has filed all reports required to be filed by it under the
Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the three years preceding the date hereof (or such shorter period as the Company was required by law to file such
material) (the foregoing materials being collectively referred to herein as the "SEC Reports" and, together with the Disclosure Schedule and the Company's Registration Statement on Form
SB-2, as amended (SEC File No. 333-111921), the "Disclosure Materials") on a timely basis or has received a valid extension pursuant to Rule 12b-25
under the Exchange Act of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading. Except as set forth in Exhibit C, all material agreements to which the Company is a party or to which the
property or assets of the Company are subject have been filed as exhibits to the SEC Reports. The financial statements of the Company included in the SEC Reports comply 



6







 




in
all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with generally accepted accounting principles ("GAAP") applied on a consistent basis during the periods involved, except as may be otherwise specified in such financial
statements or the notes thereto, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries as of the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. Except as disclosed in the Disclosure
Materials, since March 31, 2004 (a) there has been no event, occurrence or development that has had or that could reasonably be expected to have or result in a Material Adverse Effect,
(b) the Company has not incurred any liabilities (contingent or otherwise) other than (x) liabilities incurred in the ordinary course of business consistent with past practice and
(y) liabilities not required to be reflected in the Company's financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (c) the Company has
not altered its method of accounting or the identity of its auditors and (d) the Company has not declared or made any payment or distribution of cash or other property to its stockholders or
officers or directors (other than in compliance with existing Company stock option plans) with respect to its capital stock, or purchased, redeemed (or made any agreements to purchase or redeem) any
shares of its capital stock. Additionally, since the adoption of the Sarbanes-Oxley Act of 2002 (the "New Act"), the Company has complied in all material respects with the laws, rules and regulation
under the New Act which are applicable to it. 


        2.17    No Conflict of Interest.    Except as otherwise disclosed in the Disclosure Materials, the Company is not
indebted in excess of $5,000, directly or indirectly, to any of its employees, officers or directors or to their respective spouses or children, in any amount whatsoever other than in connection with
expenses or advances of expenses incurred in the ordinary course of business or relocation expenses of employees, officers and directors, nor is the Company contemplating such indebtedness as of the
date of this Agreement. Except as otherwise disclosed in the Disclosure Materials, none of said employees, officers or directors, or any member of their immediate families, is directly or indirectly
indebted to the Company (other than in connection with purchases of the Company's stock) or have any direct or indirect ownership interest in any firm or corporation with which the Company is
affiliated or with which the Company has a business relationship or any firm or corporation which competes with the
Company, nor is the Company contemplating such indebtedness as of the date of this Agreement, except that employees, officers, directors and/or shareholders of the Company may own stock in publicly
traded companies (not in excess of 1% of the outstanding capital stock thereof) which may compete with the Company. Except as otherwise disclosed in the Disclosure Materials, no employee, shareholder,
officer or director, or any member of their immediate families, is, directly or indirectly, interested in any material contract with the Company, nor does any such person own, directly or indirectly,
in whole or in part, any material tangible or intangible property that the Company uses or contemplates using in the conduct of its business. The Company is not a guarantor or indemnitor of any
indebtedness of any other Person. 




        3.     Representations and Warranties of the Investors. Each of the Investors, severally and not jointly, hereby represent and
warrant that: 



        3.1    Authorization.    The Investor represents that it has full power and authority to enter into the Transaction
Documents. The Transaction Documents entered into by the Investor constitute the valid and legally binding obligations of the Investor enforceable in accordance with their terms, except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors' rights generally and (ii) as limited 



7







 

by
laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. 


        3.2    Purchase Entirely for Own Account.    The Securities will be acquired for investment for the Investor's own
account and not with a view to the resale or distribution of any part thereof. 


        3.3    Disclosure of Information.    The Investor acknowledges that all of the Disclosure Materials were made fully
available to it and it has reviewed and understands them. The Investor acknowledges that it has received all the information that it has requested relating to the Company and the purchase of the
Units, Common Stock and the Warrants. The Investor further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the
offering of the Units, Common Stock and the Warrants. The foregoing, however, does not limit or modify the representations and warranties of the Company in Section 2 of this Agreement or the
right of the Investor to rely thereon. 


        3.4    Accredited Investor.    The Investor is an "accredited investor" within the meaning of Rule 501 of
Regulation D under the Securities Act. 


        3.5    Restricted Securities.    Investor understands that the Units, Common Stock and Warrants (and the shares of
Common Stock issuable upon exercise of the Warrants) that it is purchasing are "restricted
securities" under the federal securities laws and that under such laws and applicable regulations such securities may only be sold pursuant to an effective registration statement or an available
exemption from registration. 


        3.6    Legends.    It is understood that the certificates evidencing the Common Stock and the Warrants (and the Common
Stock issuable upon exercise thereof, respectively) may bear the following legend: 



"THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), AND ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AS SET FORTH IN
THIS CERTIFICATE. THE SECURITIES REPRESENTED HEREBY MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR AN OPINION OF COUNSEL,
REASONABLY ACCEPTABLE TO COUNSEL FOR THE COMPANY, TO THE EFFECT THAT THE PROPOSED SALE, TRANSFER, OR DISPOSITION MAY BE EFFECTUATED WITHOUT REGISTRATION UNDER THE ACT." 





        4.     Conditions of the Investors' Obligations at each Closing. The obligations of the Investors under subsection 1.1 of this
Agreement are subject to the fulfillment on or before each Closing of each of the following conditions: 



        4.1    Representations and Warranties.    The representations and warranties of the Company contained in
Section 2 hereof shall be true and correct on and as of the date of this Agreement and as of each Closing with the same effect as though such representations and warranties had been made on and
as of the date of such Closing. 


        4.2    Performance.    The Company shall have performed and complied with all agreements, obligations, and conditions
contained in this Agreement that are required to be performed or complied with by it on or before each Closing. 


        4.3    Compliance Certificate.    The President of the Company shall deliver to the Investors, at each Closing, a
certificate certifying that the conditions specified in Sections 4.1 and 4.2 have been fulfilled and stating that, except as set forth in the Disclosure Materials, there has been no material
adverse change in the business, affairs, prospects, operations, properties, assets, condition, 



8







 




capital
shares, long-term debt, results of operations, financial condition or liquidity of the Company since March 31, 2004. 


        4.4    Proceedings and Documents.    All corporate and other proceedings in connection with the transactions
contemplated at each Closing and all documents incident thereto shall be reasonably satisfactory in form and substance to the Investors and counsel to the Investors, and they shall have received all
such counterpart original and certified or other copies of such documents as they may reasonably request. 


        4.5    Opinion of Company Counsel.    The Investors shall have received from Graubard Miller an opinion, dated as of
each Closing, in form attached hereto as Exhibit D.


        4.6    Good Standing Certificates.    The Company shall have delivered to the Investors, dated as of a date within
five (5) business days of each Closing, a certificate issued by the State of Nevada to the effect that it is legally existing and in good standing. 


        4.7    Secretary's Certificate.    The Company shall have delivered to the Investors a certificate executed by the
Secretary of the Company dated as each Closing attending, true and correct copies of the following documents: (a) the resolutions adopted by the Company's Board of Directors authorizing the
transactions contemplated by this Agreement; and (b) the Amended and Restated Articles of Incorporation and Bylaws of the Company. 



        4.8    Delivery of Common Stock and Warrants    The Company shall have delivered the Common Stock and the Warrants
comprising the Units to the Investors for each Closing, as specified in Section 1. 


        4.9    Ancillary Agreements.    



        4.9.1 The
Company and the Investors shall have entered into a registration rights agreement dated of even date herewith, a form of which is attached hereto as  Exhibit E (the "Registration Rights Agreement").




        4.9.2 The
Company and Graubard Miller shall have entered into the escrow agreement dated of even date herewith, a form of which is attached hereto as  Exhibit F (the "Escrow Agreement" and together with the
Registration Rights Agreement, the "Ancillary Agreements"). 




        4.10    Other Payments.    Concurrent with each Closing, the Company shall pay the compensation set forth in
Section 7.7 hereto. 




        5.    Conditions of the Company's Obligations at each Closing.    The obligations of the Company to Investor under
this Agreement is subject to the fulfillment on or before each Closing of each of the following conditions by the Investor: 



        5.1    Representations and Warranties.    The representations and warranties of the Investors contained in
Section 3 shall be true and correct on and as of the date of this Agreement and as of each Closing with the same effect as though such representations and warranties had been made on and as of
such Closing. 


        5.2    Payment of Purchase Price.    The Investor shall have delivered the Purchase Price for the Units purchased
hereunder. 


        5.3    Ancillary Agreements.    The Company and the Investors shall have entered into the Ancillary Agreement. 




        6.    Indemnification.    



        6.1    General.    The Company agrees to indemnify and hold harmless the Investors and any of their general partners,
shareholders, employees, officers, directors, members, agents and other 



9







 

representatives
(collectively, the "Indemnitees"), against any losses, damages, liabilities, or judgments or settlements of any nature or kind, including all costs and expenses relating thereto,
including without limitation, interest, penalties and reasonable attorneys' fees (the "Losses") (joint or several) (i) arising out of any investigations, proceedings, claims or actions, to
which the Indemnitees may become subject, whether under the Securities Act or the Exchange Act or any rules or regulations promulgated thereunder, or any state law or regulation, or common law,
arising out of, related to or in any way attributable to the Indemnitee's investment in the Company, or (ii) that arise out of or are based upon any breach of any representation, warranty,
agreement, obligation or covenant of the Company contained herein or in any of the Transaction Documents. The Company also agrees to reimburse the Indemnitees for any legal or other expenses
reasonably incurred in connection with investigating or defending any such investigations, proceedings, claims or actions, as such expenses or other costs are incurred. The indemnity provided in this
Section 6.1 is not limited to Losses asserted by third parties against any Indemnitee, but includes Losses incurred or sustained by any such Indemnitee in the absence of third party claims. 



        6.2    Non-Exclusive Remedy.    The indemnification remedies provided in this Section 6 shall not
be deemed to be exclusive. Accordingly, the exercise by any person of any of its rights under this Section 6 shall not be deemed to be an election of remedies and shall not be deemed to
prejudice, or to constitute or operate as a waiver of, any other right or remedy that such person may be entitled to
exercise (whether under this Agreement, under any other contract, under any law or regulation or otherwise); provided, however, that no person shall seek other remedies in those situations where they
have received full indemnification payments with respect to such situations. 




        7.    Miscellaneous.    



        7.1    Survival of Warranties.    All of the representations and warranties made herein shall survive the execution
and delivery of this Agreement. The Investors are entitled to rely, and the parties hereby acknowledge that the Investors have so relied, upon the truth, accuracy and completeness of each of the
representations and warranties of the Company contained herein, irrespective of any independent investigation made by Investors. The Company is entitled to rely, and the parties hereby acknowledge
that the Company has so relied, upon the truth, accuracy and completeness of each of the representations and warranties of the Investors contained herein, irrespective of any independent investigation
made by the Company. 


        7.2    Successors and Assigns.    This Agreement is personal to each of the parties and may not be assigned without
the written consent of the other parties; provided, however, that any of the Investors shall be
permitted to assign its rights under this Agreement and the Ancillary Agreements to any affiliate of such Investor. 



        7.3    Governing Law.    This Agreement shall be governed by and construed under the laws of the State of New York as
applied to agreements among New York residents entered into and to be performed entirely within New York. The Company (1) agrees that any legal suit, action or proceeding arising out of or
relating to this Agreement shall be instituted exclusively in New York State Supreme Court, County of New York, or in the United States District Court for the Southern District of New York,
(2) waives any objection which the Company may have now or hereafter to the venue of any such suit, action or proceeding, and (3) irrevocably consents to the jurisdiction of the New York
State Supreme Court, County of New York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding. The Company further agrees to accept and
acknowledge service of any and all process which may be served in any such suit, action or proceeding in the New York State Supreme Court, County of New York, or in the United States District Court
for the Southern District of New York and agrees that service of process upon the Company mailed by certified mail to the Company's 



10







 




address
shall be deemed in every respect effective service of process upon the Company, in any such suit, action or proceeding. THE PARTIES HERETO AGREE TO WAIVE THEIR RESPECTIVE RIGHTS TO A JURY
TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY. 


        7.4    Counterparts.    This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission of a
copy of this Agreement bearing the signature of the party so delivering this Agreement. 



        7.5    Titles and Subtitles.    The titles and subtitles used in this Agreement are used for convenience only and are
not to be considered in construing or interpreting this Agreement. 


        7.6    Notices.    Unless otherwise provided, any notice, authorization, request or demand required or permitted to be
given under this Agreement shall be given in writing and shall be deemed effectively given upon personal delivery to the party to be notified or three (3) days following deposit with the United
States Post Office, by registered or certified mail, postage prepaid, or two days after it is sent by an overnight delivery service, or when sent by facsimile with machine confirmation of delivery
addressed as follows: 



If
to the Investors to: 


The
address set forth opposite their name on the Schedule of Investors attached hereto 


If
to Company, to: 


Vital
Living, Inc.

5080 North 40th Street,

Suite 105, Phoenix, AZ 85018

Telecopier No.: (602) 952-7129

Attention: Stuart A. Benson, President (e-mail: cafestu@aol.com) 



In
either case, with a copy to: 


HCFP/Brenner
Securities, LLC

888 Seventh Avenue

17th Floor

New York, New York 10106

Telecopier No.: (212) 707-0378

Attention: Ira Greenspan (e-mail: igreenspan@hcfpbrenner.com) 


and



Graubard
Miller

600 Third Avenue

New York, New York 10016

Telecopier No.: (212) 818-8881

Attention: David Alan Miller, Esq. (e-mail: dmiller@graubard.com) 





Any
party may change its address for such communications by giving notice thereof to the other parties in conformity with this Section. 



        7.7    Finder's Fee.    Each party represents that it neither is nor will be obligated for any finders' or brokers'
fee or commission in connection with this transaction; provided, however, that 



11







 

the
Company is obligated to pay certain compensation upon consummation of the transactions contemplated hereby to Brenner. 



        7.8    Transaction Expenses; Enforcement of Transaction Documents.    The Company and each Investor shall pay their
respective costs and expenses incurred with respect to the negotiation, execution, delivery and performance of this Agreement. If any action at law or in equity is necessary to enforce or interpret
the terms of the Transaction Documents, the prevailing party shall be entitled to reasonable attorney's fees, costs, and necessary disbursements in addition to any other relief to which such party may
be entitled. 


        7.9    Amendments and Waivers.    No provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each of the Investors or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought 


        7.10    Severability.    If one or more provisions of this Agreement are held to be unenforceable under applicable
law, such provision shall be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its
terms. 


        7.11    Entire Agreement.    This Agreement and the documents referred to herein constitute the entire agreement among
the parties and no party shall be liable or bound to any other party in any manner by any warranties, representations, or covenants except as specifically set forth herein or therein. 


        7.12    Additional Investors.    In the event that, at any time or from time to time, the Company holds an Interim
Closing and issues additional Units to additional investors (collectively the "Additional Investors" and individually an "Additional Investor"), as a condition precedent to such Closing, the Company
shall countersign a copy of this Agreement with each Additional Investor and each such Additional Investor shall agree to sign a copy of this Agreement (for and on behalf of himself or itself, his or
its legal representatives and his or its transferees and assigns) thereby agreeing to be bound by all applicable provisions of this Agreement as a party hereto and in the capacity as an Investor.
Except as provided herein, upon any such Interim Closing, all references to the Investors or to any Investor shall thereafter be deemed to include such Additional Investors, and upon such Closing,
each such Additional Investor shall be added to the Schedule of Investors. 




        IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 



	

 	
 	

Vital Living, Inc.
	

 	
 	

By:	

/s/  STUART BENSON      






	 	 	Name: Stuart Benson

Title: Chief Executive Officer
	

 	
 	
EACH OF THE INVESTORS SET FORTH ON

THE ATTACHED SCHEDULE OF INVESTORS




12







 
SCHEDULE OF INVESTORS  



	Name and Address
 
	 	Number of Units
	 	Purchase Price
	 	Signature

	Stewart Richer

2 Horatio Street, Apt. 15G

New York, New York 10014	 	400,000	 	$	100,000	 	/s/ Stewart Richer
	

Edward S. Gutman

100 United Nations Plaza

New York, New York 10017	
 	

400,000	
 	
$	

100,000	
 	

/s/ Edward S. Gutman
	

The Edward S. Gutman Family Foundation

c/o Edward S. Gutman

100 United Nations Plaza

New York, New York 10017	
 	

400,000	
 	
$	

100,000	
 	

/s/ Edward S. Gutman
	

Joseph Catalano

203 Carnation Drive

Farmingdale, New York 11735	
 	

100,000	
 	
$	

25,000	
 	

/s/ Joseph Catalano
	

Silverman Partners

791 Park Avenue, 5B

New York, New York 10021	
 	

1,200,000	
 	
$	

300,000	
 	

/s/ General Partner




13











QuickLinks



Exhibit 4.30


SECURITIES PURCHASE AGREEMENT BY AND BETWEEN VITAL LIVING, INC. AND THE INVESTORS

SECURITIES PURCHASE AGREEMENT